← EyePoint Pharmaceuticals, Inc.
What podcasts say about EyePoint Pharmaceuticals, Inc.
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about EyePoint Pharmaceuticals, Inc.
2 statements · 1 negative · 1 mixed
EyePoint’s experimental eye-disease treatment failed its late-stage primary endpoint.
“the drug developer said its experimental treatment for an eye disease failed to meet a primary goal in its late stage trial.”
Open the episode · Closing Bell: Chip Stocks Rise, SpaceX Gains, EyePoint SinksListen at 3:15
EyePoint’s failed trial does not necessarily end its prospects.
“that doesn't necessarily mean this is the end.”
Open the episode · Closing Bell: Chip Stocks Rise, SpaceX Gains, EyePoint SinksListen at 3:46
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.